7月14日 - 强生公司（JNJ.N）股价上涨1.9%，至252.77美元，该公司将于周三开盘前公布季度财报
** 华尔街分析师预计，强生公司（JNJ）的调整后每股收益将增长约3%，至2.85美元；营收预计增长5.50%，至250亿美元
** 在过去8个季度中，强生公司的营收和调整后每股收益每次均达到或超过了分析师预期
** JNJ的医疗器械子公司Abiomed在马萨诸塞州的一场陪审团审判中胜诉 (link)，此前该公司被指控侵犯了Maquet Cardiovascular在心脏泵技术方面的专利权。
** 据LSEG数据显示，在27位覆盖强生（JNJ）的分析师中，平均评级为“买入”，目标价中位数为264美元
** 今年迄今，强生股价上涨22.3%，而同期标普500医疗指数 .SPXHC 仅上涨2.25%
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.